- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
The third most common childhood cancer is lymphoma; it accounts for 10% of all childhood cancer diagnoses. Of these diagnoses, about 60% are Non-Hodgkin’s Lymphomas. Children are vulnerable to the same types of lymphoma as adults. Although diagnosis of lymphoma in a child is especially traumatic for everyone involved, it must be remembered that younger patients generally have higher recovery rates than adults. This page briefly outlines non-Hodgkin's lymphoma; please use the numerous hyperlinks for more in depth information.
Non-Hodgkin’s Lymphoma (NHL) is a cancerous growth of B-cells or T-cells in the lymphatic system. There are four main types that occur in children:
[More on childhood NHL statistics from ACS]
Lymphomas present a wide range of symptoms, all of which can indicate less severe conditions. However, if you or your child exhibits several of these symptoms, an appointment with a doctor would be wise.
After treatment, a child's health may still be affected by health problems that show up after cancer treatment (sometimes years later). These are known as a "late effects." For this reason, your child's health must be closely monitored throughout the remainder of their lives. For more information, see the American Cancer Society's Childhood Cancer: Late Effects of Cancer Treatment.
Photo by Jyn Meyer